Dr. Yusuf Hamied, head of the Indian pharmaceutical and generics manufactured by Cipla, is weighing options for how to continue to support the global fight against HIV / AIDS, while positioning the company for growth in a changing regulatory framework. "Hide
by Rohit Deshpande, Sandra J. Sucher Laura Winig Source: HBS Premier Case Collection 26 pages. Publication date: April 12, 2011. Prod. #: 511050-PDF-ENG
